Please login to the form below

Not currently logged in


This page shows the latest Zafgen news and features for those working in and with pharma, biotech and healthcare.

Zafgen shares tumble after FDA places hold on diabetes trial

Zafgen shares tumble after FDA places hold on diabetes trial

Zafgen already has a phase 2 trial of ZGN-1061 ongoing outside the US, which includes a 1.8 mg dose cohort. ... Zafgen came close to running out of cash when it was forced to abandon beloranib, and had to drastically scale back its operations and staff.

Latest news

  • Second patient death in Zafgen's obesity drug trial

    A second patient enrolled in a phase III trial of Zafgen's obesity drug candidate beloranib has died, placing the future of the programme in doubt. ... Thomas Hughes, Zafgen's chief executive, said: "Our thoughts are with the patient and their family at

More from news
Approximately 2 fully matching, plus 0 partially matching documents found.

Featured jobs

Subscribe to our email news alerts


Add my company
GCI Health

GCI Health London is a young, vibrant powerhouse in the European industry with a mission to redefine healthcare communications, starting...

Latest intelligence

50 questions for delivering an exceptional healthcare brand experience
Our 50-question brand planning checklist for healthcare ensures you deliver an exceptional experience, based on what your stakeholders want and need...
The brand strategy revolution
Introducing a new tool for developing a stakeholder-centric brand, based on the experience your patients and their HCPs want and need....
How Medisafe is using AI to improve patient adherence
Dina Patel speaks to Omri Shor, Co-Founder and CEO of Medisafe, to find out how his medication management app is tackling the problem of poor adherence....